Marco C. Becx

Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial

Marin J. de Jong, Andrea E. van der Meulen‐de Jong, Mariëlle Romberg‐Camps et al. · The Lancet · 2017 · 347 citations · Full text

Wireless Telemedicine, Remote Patient Monitoring, Telemedicine +8

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

Hubert J. F. van Hoogstraten, Frank H.J. Wolfhagen, Paul C. van de Meeberg et al. · Journal of Hepatology · 1998 · 84 citations

Hepatology, Biliary Tract, Ursodeoxycholic Acid Therapy +6

Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD

Marin de Jong, Andrea E. van der Meulen‐de Jong, Mariëlle Romberg‐Camps et al. · Inflammatory Bowel Diseases · 2017 · 83 citations · Full text

Severe Hepatic Side Effects of Ezetimibe

Mark F.J. Stolk, Marco C. Becx, Karel C. Kuypers et al. · Clinical Gastroenterology and Hepatology · 2006 · 63 citations · Full text

Hepatology, Medicine, Liver Physiology +7

Novel Perceived Stress and Life Events Precede Flares of Inflammatory Bowel Disease: A Prospective 12-Month Follow-Up Study

D Wintjens, Marin J. de Jong, Andrea E. van der Meulen‐de Jong et al. · Journal of Crohn s and Colitis · 2018 · 46 citations · Full text